786 related articles for article (PubMed ID: 16406544)
1. Multifocal visual evoked potential analysis of inflammatory or demyelinating optic neuritis.
Fraser CL; Klistorner A; Graham SL; Garrick R; Billson FA; Grigg JR
Ophthalmology; 2006 Feb; 113(2):323.e1-323.e2. PubMed ID: 16406544
[TBL] [Abstract][Full Text] [Related]
2. Multifocal visual evoked potential latency analysis: predicting progression to multiple sclerosis.
Fraser C; Klistorner A; Graham S; Garrick R; Billson F; Grigg J
Arch Neurol; 2006 Jun; 63(6):847-50. PubMed ID: 16769865
[TBL] [Abstract][Full Text] [Related]
3. A comparative study of visual evoked potentials in optic neuritis and optic neuritis with multiple sclerosis.
Samsen P; Chuenkongkaew WL; Masayaanon P; Chirapapaisan N; Ruangvaravate N; Loket S
J Med Assoc Thai; 2007 Feb; 90(2):313-8. PubMed ID: 17375637
[TBL] [Abstract][Full Text] [Related]
4. Predictive role of evoked potential examinations in patients with clinically isolated optic neuritis in light of the revised McDonald criteria.
Simó M; Barsi P; Arányi Z
Mult Scler; 2008 May; 14(4):472-8. PubMed ID: 18208873
[TBL] [Abstract][Full Text] [Related]
5. Outcome measures for trials of remyelinating agents in multiple sclerosis: retrospective longitudinal analysis of visual evoked potential latency.
Niklas A; Sebraoui H; Hess E; Wagner A; Then Bergh F
Mult Scler; 2009 Jan; 15(1):68-74. PubMed ID: 18701569
[TBL] [Abstract][Full Text] [Related]
6. Progression of visual evoked potential abnormalities in multiple sclerosis and optic neuritis.
Alshuaib WB
Electromyogr Clin Neurophysiol; 2000 Jun; 40(4):243-52. PubMed ID: 10907603
[TBL] [Abstract][Full Text] [Related]
7. Fellow eye changes in optic neuritis correlate with the risk of multiple sclerosis.
Klistorner A; Arvind H; Nguyen T; Garrick R; Paine M; Graham S; Yiannikas C
Mult Scler; 2009 Aug; 15(8):928-32. PubMed ID: 19498018
[TBL] [Abstract][Full Text] [Related]
8. Axonal loss and myelin in early ON loss in postacute optic neuritis.
Klistorner A; Arvind H; Nguyen T; Garrick R; Paine M; Graham S; O'Day J; Grigg J; Billson F; Yiannikas C
Ann Neurol; 2008 Sep; 64(3):325-31. PubMed ID: 18825673
[TBL] [Abstract][Full Text] [Related]
9. Stereoacuity testing discloses abnormalities in multiple sclerosis without optic neuritis.
Sobaci G; Demirkaya S; Gundogan FC; Mutlu FM
J Neuroophthalmol; 2009 Sep; 29(3):197-202. PubMed ID: 19726941
[TBL] [Abstract][Full Text] [Related]
10. Electrophysiological evidence for heterogeneity of lesions in optic neuritis.
Klistorner A; Graham S; Fraser C; Garrick R; Nguyen T; Paine M; O'Day J; Grigg J; Arvind H; Billson FA
Invest Ophthalmol Vis Sci; 2007 Oct; 48(10):4549-56. PubMed ID: 17898277
[TBL] [Abstract][Full Text] [Related]
11. Multifocal blue-on-yellow visual evoked potentials in early glaucoma.
Klistorner A; Graham SL; Martins A; Grigg JR; Arvind H; Kumar RS; James AC; Billson FA
Ophthalmology; 2007 Sep; 114(9):1613-21. PubMed ID: 17822971
[TBL] [Abstract][Full Text] [Related]
12. An interocular comparison of the multifocal VEP: a possible technique for detecting local damage to the optic nerve.
Hood DC; Zhang X; Greenstein VC; Kangovi S; Odel JG; Liebmann JM; Ritch R
Invest Ophthalmol Vis Sci; 2000 May; 41(6):1580-7. PubMed ID: 10798679
[TBL] [Abstract][Full Text] [Related]
13. Tracking the recovery of local optic nerve function after optic neuritis: a multifocal VEP study.
Hood DC; Odel JG; Zhang X
Invest Ophthalmol Vis Sci; 2000 Nov; 41(12):4032-8. PubMed ID: 11053309
[TBL] [Abstract][Full Text] [Related]
14. [Early diagnosis of optic nerve neuropathy in multiple sclerosis].
Nizankowska MH; Turno-Krecicka A; Misiuk-Hojło M; Ejma M; Batycka-Ugorska I
Klin Oczna; 1996 Jan; 98(1):21-5. PubMed ID: 9019570
[TBL] [Abstract][Full Text] [Related]
15. [Comparative study of visual evoked potentials and magnetic resonance imaging in multiple sclerosis].
Miletto G; Merlihot JM; Nezri M; Stanoyevitch JF; Pernet-Rambaud C; Houis B
J Fr Ophtalmol; 1988; 11(1):67-73. PubMed ID: 3385127
[TBL] [Abstract][Full Text] [Related]
16. Axonal loss in the retinal nerve fiber layer in patients with multiple sclerosis.
Pueyo V; Martin J; Fernandez J; Almarcegui C; Ara J; Egea C; Pablo L; Honrubia F
Mult Scler; 2008 Jun; 14(5):609-14. PubMed ID: 18424482
[TBL] [Abstract][Full Text] [Related]
17. Subclinical visual involvement in multiple sclerosis: a study by MRI, VEPs, frequency-doubling perimetry, standard perimetry, and contrast sensitivity.
Sisto D; Trojano M; Vetrugno M; Trabucco T; Iliceto G; Sborgia C
Invest Ophthalmol Vis Sci; 2005 Apr; 46(4):1264-8. PubMed ID: 15790888
[TBL] [Abstract][Full Text] [Related]
18. [Visual evoked potentials, contrast sensitivity and color perception in patients with optic nerve neuritis and multiple sclerosis].
Bürki E
Klin Monbl Augenheilkd; 1981 Sep; 179(3):161-8. PubMed ID: 7300224
[TBL] [Abstract][Full Text] [Related]
19. Optic nerve diffusion changes and atrophy jointly predict visual dysfunction after optic neuritis.
Kolbe S; Chapman C; Nguyen T; Bajraszewski C; Johnston L; Kean M; Mitchell P; Paine M; Butzkueven H; Kilpatrick T; Egan G
Neuroimage; 2009 Apr; 45(3):679-86. PubMed ID: 19162205
[TBL] [Abstract][Full Text] [Related]
20. The effect of corticosteroids for acute optic neuritis on the subsequent development of multiple sclerosis. The Optic Neuritis Study Group.
Beck RW; Cleary PA; Trobe JD; Kaufman DI; Kupersmith MJ; Paty DW; Brown CH
N Engl J Med; 1993 Dec; 329(24):1764-9. PubMed ID: 8232485
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
